🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 3 double-blind, randomized, placebo-controlled, study to as...
Status
Recruiting
Location
First Affiliated Hospital of Soochow University
Start Date
2021-06-07
Trial ID
NCT04853342
Treatments Being Tested
A Single-Arm Clinical Study of Furmonertinib (160mg) Combined with Intrathe...
Status
Recruiting
Location
CANGZHOU People's Hospital
Start Date
2025-12-22
Trial ID
NCT07304739
Treatments Being Tested
Global, Phase 3, randomized, multicenter, open-label study evaluating the e...
Status
Recruiting
Location
St. Jude Medical Center
Start Date
2025-12-17
Trial ID
NCT07185997
Treatments Being Tested
In this single-arm, phase II clinical trial, patients with resectable, EGFR...
Status
Active Not Recruiting
Location
Tangdu Hospital
Start Date
2022-02-24
Trial ID
NCT05430802
Treatments Being Tested
EGFR mutation positive advanced NSCLC patients with uncleared ctDNA have po...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2022-05-06
Trial ID
NCT05334277
The purpose of this study is to assess the Treatment Strategies and Surviva...
Status
Recruiting
Location
Yongchang Zhang
Start Date
2020-04-16
Trial ID
NCT04322890
Treatments Being Tested
This study is a Phase III, international, multicenter, randomized, controll...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-09-26
Trial ID
NCT06970639
Evaluate the efficacy and safety of neoadjuvant furmonertinib combined with...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-10-01
Trial ID
NCT06585644
Treatments Being Tested
This is a phase II, prospective, multi-centre study. To assess the efficacy...
Status
Recruiting
Location
Sichuan cancer hospital
Start Date
2023-12-31
Trial ID
NCT06192849
Treatments Being Tested
Disitamab Vedotin combined therapy locally advanced or metastatic NSCLC Pat...
Status
Unknown
Location
SunYat-senU
Start Date
2023-05
Trial ID
NCT05847764
Treatments Being Tested